Investigational Site Number 8930

Burlington, Vermont 05401

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis — Completed